Active ingredients: Salicylic acid, Lactic acid
VERUNEC 15 g + 15 g / 100 g collodion
Why is Verunec used? What is it for?
Verunec is a viscous solution (collodion) to be applied to the skin containing the active ingredients salicylic acid and lactic acid which belong to the category of keratolytics. Keratolytics work by softening hard and thickened (callused) skin and favoring its elimination.
Verunec is indicated to treat:
- vulgar, plantar, mosaic warts. By wart we mean a characteristic skin formation differently classified according to the area of appearance and the responsible virus
- corns and calluses (hard and thick pads due to pressure and friction of the skin).
Talk to your doctor if you do not feel better or if you feel worse after a short period of treatment.
Contraindications When Verunec should not be used
Do not use Verunec
- if you are allergic to salicylic acid, lactic acid or any of the other ingredients of this medicine (listed in section 6)
- if you have diabetes
- if you suffer from blood circulation disorders
- on the face and on the anogenital area, as in the case of all products with a high content of salicylic acid due to its irritating effect.
Precautions for use What you need to know before taking Verunec
Talk to your doctor or pharmacist before using Verunec.
- Do not apply the medicine on: seborrheic warts, facial warts, genital warts (condylomas), skin moles (skin nevi).
- Avoid contact of this medicine with the eyes and mucous membranes. In case of contact with the eyes or mucous membranes, wash with water, remove the residue formed and wash again with water for 15 minutes.
- Avoid applying Verunec to normal skin surrounding the calloused area.
- The use, especially if prolonged, of the products to be applied on the skin can give rise to sensitization phenomena (allergy to one or more components). In this case, stop the treatment and consult the doctor who will adopt an adequate therapy.
- Do not use Verunec to prevent warts from forming.
- Do not use this medicine for prolonged treatments; after a short period of treatment without appreciable results, consult your doctor.
Interactions Which drugs or foods may change the effect of Verunec
Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.
Do not use other keratolytics at the same time as Verunec as they can increase the aggressive action of the active ingredients.
Warnings It is important to know that:
Pregnancy and breastfeeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.
As the safety of use of this medicine during pregnancy has not been established, use it only when clearly needed and under the supervision of your doctor.
Driving and using machines
Verunec does not affect the ability to drive or use machines.
Dose, Method and Time of Administration How to use Verunec: Posology
Always use this medicine exactly as described in this leaflet or as directed by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist.
Apply a small amount of medicine to the affected area 2 times a day (morning and evening) with the special spatula. Let it evaporate for a few minutes.
Verunec leaves a protective film that does not require special attention and that is easily removed when it is necessary to carry out subsequent applications.
Before using this medicine, the following procedure is recommended: wet the application area for about 5 minutes in hot water and rub it with an abrasive stone or file from time to time (2-3 times a week).
Continue the treatment until the callus has been completely eliminated.
Do not exceed the recommended dose.
Overdose What to do if you have taken too much Verunec
No cases of overdose have been reported. However, in case of application of an excessive dose of medicine wash immediately and thoroughly with water and consult your doctor.
Verunec is for external use only. Do not swallow this medicine. In case of accidental ingestion / intake of Verunec, notify your doctor immediately or go to the nearest hospital.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Side Effects What are the side effects of Verunec
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you happen to apply the medicine to the skin surrounding the hyperkeratotic formation (wart or callus), you may experience a "localized irritation that you can control by temporarily stopping" the application. When you resume treatment, take care to apply the medicine only to the affected area.
Compliance with the instructions contained in the package leaflet reduces the risk of undesirable effects.
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system at www.agenziafarmaco.gov.it/it/responsabili. By reporting side effects you can help provide more information on the safety of this medicine.
Expiry and Retention
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the package after EXP. The expiry date refers to the last day of that month.
The product is flammable, keep the bottle tightly closed and away from flames or heat sources.
Do not throw any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. This will help protect the environment.
Deadline "> Other information
What Verunec contains
- The active ingredients are salicylic acid and lactic acid. 100 g of collodion contains 15 g of salicylic acid and 15 g of lactic acid.
- The other ingredients are: urea, glycerin, USP elastic collodion (composed of camphor, castor oil, pyroxylin, ethyl ether, ethyl alcohol).
What Verunec looks like and contents of the pack
Verunec is a collodion contained in a 10 gram glass bottle with cap with applicator.
Source Package Leaflet: AIFA (Italian Medicines Agency). Content published in January 2016. The information present may not be up-to-date.
To have access to the most up-to-date version, it is advisable to access the AIFA (Italian Medicines Agency) website. Disclaimer and useful information.
01.0 NAME OF THE MEDICINAL PRODUCT -
VERUNEC 15 G + 15 G / 100 G COLLODIUM
02.0 QUALITATIVE AND QUANTITATIVE COMPOSITION -
100 g of collodion contain:
Active principles: SALICYLIC ACID 15 g, LACTIC ACID 15 g.
03.0 PHARMACEUTICAL FORM -
Collodion
04.0 CLINICAL INFORMATION -
04.1 Therapeutic indications -
Treatment of vulgar, plantar, mosaic warts; corns and calluses.
04.2 Posology and method of administration -
Apply a small amount of product on the affected area twice a day (morning and evening), using the special spatula.
Let it evaporate for a few minutes.
VERUNEC leaves a protective film that does not require special attention and is easily removable for subsequent applications.
Before using the product, it is advisable to wet the area of application for about 5 minutes in hot water and, from time to time (2-3 times a week), to rub it with an abrasive stone or file.
The treatment should be continued until the callosity is completely removed.
Do not exceed the recommended dose.
04.3 Contraindications -
Hypersensitivity to the active substances or to any of the excipients.
VERUNEC should not be used by diabetics or patients with impaired blood circulation.
VERUNEC like all products with a high content of salicylic acid should not be applied to the face and anogenital area.
04.4 Special warnings and appropriate precautions for use -
The product must not be applied on: seborrheic warts, facial warts, warts, skin nevi.
Avoid contact with eyes and mucous membranes.
Should the product be spilled into the eyes or mucous membranes, wash with water, remove the precipitated collodion and wash again with water for 15 minutes.
Avoid application to normal skin surrounding the callus.
The product is for external use only.
The use, especially prolonged, of products for topical use can give rise to sensitization phenomena. In this case, stop the treatment and consult the doctor to establish a suitable therapy.
Do not swallow. In case of accidental ingestion of the product consult a doctor immediately.
The product should not be used to prevent the formation of warts.
Keep out of reach of children.
Do not use for prolonged treatments; after a short period of treatment without appreciable results, consult your doctor.
04.5 Interactions with other medicinal products and other forms of interaction -
Avoid the simultaneous use of other keratolytics in order not to increase the caustic action of the active substances.
04.6 Pregnancy and breastfeeding -
The safety of use in pregnancy has not been ascertained, therefore the product should be used only in case of real need and under the supervision of a doctor.
04.7 Effects on ability to drive and use machines -
There are no known effects on the ability to drive and use machines.
04.8 Undesirable effects -
Localized irritation may occur if the product is applied to the skin surrounding the hyperkeratotic formation.
Normally the irritation should be controlled by the temporary suspension and by applying the product only to the affected area when the treatment is resumed.
04.9 Overdose -
No cases of overdose have been reported. However, in case of application of an excessive dose of product, wash immediately and thoroughly with water and consult your doctor.
05.0 PHARMACOLOGICAL PROPERTIES -
05.1 "Pharmacodynamic properties -
Salicylic Acid is an irritating drug for gastric mucosa and tissues and can only be used topically.
It is an effective and widely used keratolytic, it produces desquamation and destruction of the epithelium by solubilizing the intercellular cement of the stratum corneum. It also has fungicidal properties.
Lactic Acid intervenes on the keratinization process by reducing hyperkeratosis; being moreover caustic it determines the destruction of the hyperkeratotic tissue.
05.2 "Pharmacokinetic properties -
It is a preparation for topical use, to be used on skin surfaces of very limited size.
Under normal conditions of use in patients suffering from warts the percutaneous absorption of the components is completely negligible.
05.3 Preclinical safety data -
For Salicylic Acid, the LD50 in rabbits is 1.3 g / kg per os. The minimum lethal dose is 15 g.
For lactic acid the LD50 is 3.73 g / kg orally in the rat.
06.0 PHARMACEUTICAL INFORMATION -
06.1 Excipients -
Urea, glycerin, USP elastic collodion (composed of camphor, castor oil, pyroxylin, ethyl ether, ethyl alcohol).
06.2 Incompatibility "-
Salicylic acid is incompatible with: iron salts, ethyl nitrite, alcoholic solution, lead acetate, iodine.
Lactic acid is incompatible with: oxidizing agents, iodides, nitric acid, albumin.
06.3 Period of validity "-
Two years.
06.4 Special precautions for storage -
The product is flammable, keep the bottle tightly closed and away from flames or heat sources.
06.5 Nature of the immediate packaging and contents of the package -
10g glass bottle with cap with applicator.
06.6 Instructions for use and handling -
None in particular.
07.0 HOLDER OF THE "MARKETING AUTHORIZATION" -
SAVOMA MEDICINALI S.p.A. - Via Baganza N.2 / A - 43125 PARMA
08.0 MARKETING AUTHORIZATION NUMBER -
Code: 034603011
09.0 DATE OF FIRST AUTHORIZATION OR RENEWAL OF THE AUTHORIZATION -
A.I.C renewal: April 2011
10.0 DATE OF REVISION OF THE TEXT -
April 2011
